tiprankstipranks
Trending News
More News >

Grand Pharmaceutical Group Enters Strategic Collaboration with Sirtex Medical US

Story Highlights
Grand Pharmaceutical Group Enters Strategic Collaboration with Sirtex Medical US

Confident Investing Starts Here:

Grand Pharmaceutical Group Limited ( (HK:0512) ) has issued an update.

Grand Pharmaceutical Group Limited announced a Business Collaboration Agreement between its subsidiary Chengdu Shetai and Sirtex Medical US. This agreement allows both parties to engage each other for services related to research and development of medical device and radiopharmaceutical products, with a financial cap of US$1.2 million annually. The collaboration is expected to enhance the company’s capabilities in clinical development and logistics support, potentially strengthening its position in the medical industry.

More about Grand Pharmaceutical Group Limited

Grand Pharmaceutical Group Limited is a company involved in the medical industry, focusing on the research and development of medical device products and radiopharmaceutical products. The company collaborates with various partners to enhance its offerings in treatment methods for human diseases.

YTD Price Performance: 29.63%

Average Trading Volume: 9,231,823

Technical Sentiment Signal: Sell

Current Market Cap: HK$21.12B

See more data about 0512 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App